B7-H3 Expression and Resistance Mechanisms in Prostate Cancer - Di Zhao
Di Zhao presents preclinical work on B7-H3, an overexpressed immune checkpoint molecule in prostate cancer that rises with disease progression and is associated with worse outcomes. Using the antibody-drug conjugate DS-7300a, now in phase 3 trials, Dr. Zhao found p53 loss confers resistance…